Advertisement

Percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for rheumatic mitral and aortic stenosis

      Abstract

      The indications for transfemoral transcatheter aortic valve replacement (TAVR) have been expanding; however, treatment protocol for patients with severe aortic stenosis with other significant valve disease is still controversial. Furthermore, there are few randomized data to guide therapy in multivalvular disease. We describe a successful percutaneous transvenous mitral commissurotomy and TAVR simultaneously. A 3-year follow-up echocardiography showed preserved valve function.

      Learning objective

      A combination of percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for multivalvular disease with severe mitral stenosis and aortic stenosis may be a treatment option. For multivalvular disease, heart team decisions can be valuable for an optimal management strategy.

      Abbreviations:

      TAVR (Transcatheter Aortic Valve Replacement), PTMC (Percutaneous Transvenous Mitral Commissurotomy), AS (Aortic Stenosis), MS (Mitral Stenosis)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology Cases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Joseph L.
        • Bashir M.
        • Xiang Q.
        • Yerokun B.A.
        • Matsouaka R.A.
        • Vemulapalli S.
        • et al.
        Prevalence and outcomes of mitral stenosis in patients undergoing transcatheter aortic valve replacement: findings from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapies registry.
        JACC Cardiovasc Interv. 2018; 11: 693-702https://doi.org/10.1016/j.jcin.2018.01.245
        • Unger P.
        • Lancellotti P.
        • de Cannière D.
        The clinical challenge of concomitant aortic and mitral valve stenosis.
        Acta Cardiol. 2016; 71: 3-6https://doi.org/10.2143/AC.71.1.3132091
        • Unger P.
        • Tribouilloy C.
        Aortic stenosis with other concomitant valvular disease: aortic regurgitation, mitral regurgitation, mitral stenosis, or tricuspid regurgitation.
        Cardiol Clin. 2020; 38: 33-46https://doi.org/10.1016/j.ccl.2019.09.002
        • Vassileva C.M.
        • Li S.
        • Thourani V.H.
        • Suri R.M.
        • et al.
        Outcome characteristics of multiple-valve surgery: comparison with single-valve procedures.
        Innovations (Phila). 2014; 9 (PMID: 24402042): 27-32https://doi.org/10.1097/IMI.0000000000000028
        • Sharma S.
        • Loya Y.S.
        • Desai D.M.
        • Pinto R.J.
        Percutaneous double-valve balloon valvotomy for multivalve stenosis: immediate results and intermediate-term follow-up.
        Am Heart J. 1997; 133: 64-70https://doi.org/10.1016/S0002-8703(97)70249-7
        • Misuraca L.
        • Farah B.
        • Tchetche D.
        Concomitant transapical treatment of aortic stenosis and degenerated mitral bioprosthesis with two 29 mm Edwards sapien XT prostheses.
        J Invasive Cardiol. 2013; 25: 680-682
        • Baumgartner H.
        • Falk V.
        • Bax J.J.
        • De Bonis M.
        • Hamm C.
        • Holm P.J.
        • et al.
        ESC/EACTS guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the european Society of Cardiology (ESC) and the european Association for Cardio-Thoracic Surgery (EACTS).
        Eur Heart J. 2017; 38: 2739-2791https://doi.org/10.1093/eurheartj/ehx391
        • Nishimura R.A.
        • Otto C.M.
        • Bonow R.O.
        • Carabello B.A.
        • Fleisher L.A.
        • Jneid H.
        • Mack M.J.
        • McLeod C.J.
        • O'Gara P.T.
        • Rigolin V.H.
        • Thompson A.
        • Erwin III, J.P.
        • Sundt III, T.M.
        2017 AHA/ACC focused update of the 2014 AHA /ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines..
        Circulation. 2017; 135: e1159-e1195